Impedimed Ltd (OTCPK:IPDQF)
$ 0.048 0 (0%) Market Cap: 70.20 Mil Enterprise Value: 54.36 Mil PE Ratio: 0 PB Ratio: 2.40 GF Score: 0/100

Q3 2020 ImpediMed Ltd Earnings Call Transcript

Apr 15, 2020 / 11:15PM GMT
Release Date Price: $0.0228
Operator

Thank you for standing by. And welcome to the ImpediMed Limited quarterly results investor conference call. (Operator Instructions)

I would now like to hand the conference over to Mr. Richard Carreon, Managing Director and CEO. Please go ahead.

Richard Carreon
ImpediMed Limited - MD, CEO, President & Executive Director

Thank you, Lexy. Good morning, good afternoon and good evening. And thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending 31 March, 2020.

Before I begin, I'd like to acknowledge and thank the clinicians, caregivers, staff and all those involved in the fight against COVID-19. And although the fight is far from over, the courage these individuals show every day is nothing short of remarkable.

On today's call, I'll be referencing the 4C we launched this morning Australian time. Due to the possibility of communications problem impacting this conference call, I have asked Mike Bassett, our Senior Vice President of Corporate and Strategic Development, to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot